Enveric Biosciences, Inc. (ENVB) vs InMed Pharmaceuticals Inc. (INM)
A side-by-side comparison of Enveric Biosciences, Inc. and InMed Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ENVB
Enveric Biosciences, Inc.
$1.47HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
INM
InMed Pharmaceuticals Inc.
$1.33HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ENVB vs INM
growth of $100 · dividends reinvested · last 10yENVB -100.0% (-75.0%/yr)INM -99.9% (-52.6%/yr)INM compounded faster over this window
Log scale — wide-divergence pair
ENVB INM
ENVB vs INM: by the numbers
- •INM is the larger company ($7M vs $7M market cap).
- •Both run net losses; ENVB's is the smaller (0.00% vs -0.61% net margin).
Metrics side by side
Valuation
| Metric | ENVB | INM |
|---|---|---|
| P/S ratio | N/A | 0.00 |
| P/B ratio | 0.81 | 6.80 |
Profitability
| Metric | ENVB | INM |
|---|---|---|
| Gross margin | 0.00% | 14.92% |
| Operating margin | 0.00% | -0.52% |
| Net margin | 0.00% | -0.61% |
| ROE | -108.00% | -1168.44% |
| ROIC | -107.99% | -995.44% |
Growth (annualized)
| Metric | ENVB | INM |
|---|---|---|
| Total return CAGR (5Y) | N/A | -71.98% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.